175 related articles for article (PubMed ID: 17850589)
21. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
[TBL] [Abstract][Full Text] [Related]
22. Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes.
Bousso P; Robey E
Nat Immunol; 2003 Jun; 4(6):579-85. PubMed ID: 12730692
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
24. Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses.
Hugues S; Scholer A; Boissonnas A; Nussbaum A; Combadière C; Amigorena S; Fetler L
Nat Immunol; 2007 Sep; 8(9):921-30. PubMed ID: 17660821
[TBL] [Abstract][Full Text] [Related]
25. Tetraspanins CD37 and CD151 differentially regulate Ag presentation and T-cell co-stimulation by DC.
Sheng KC; van Spriel AB; Gartlan KH; Sofi M; Apostolopoulos V; Ashman L; Wright MD
Eur J Immunol; 2009 Jan; 39(1):50-5. PubMed ID: 19089816
[TBL] [Abstract][Full Text] [Related]
26. Observation of antigen-dependent CD8+ T-cell/ dendritic cell interactions in vivo.
Schaefer BC; Schaefer ML; Kappler JW; Marrack P; Kedl RM
Cell Immunol; 2001 Dec; 214(2):110-22. PubMed ID: 12088410
[TBL] [Abstract][Full Text] [Related]
27. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
[TBL] [Abstract][Full Text] [Related]
28. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses.
Bedoui S; Prato S; Mintern J; Gebhardt T; Zhan Y; Lew AM; Heath WR; Villadangos JA; Segura E
J Immunol; 2009 Apr; 182(7):4200-7. PubMed ID: 19299718
[TBL] [Abstract][Full Text] [Related]
29. The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
Terme M; Mignot G; Ullrich E; Bonmort M; Minard-Colin V; Jacquet A; Schultze JL; Kroemer G; Leclerc C; Chaput N; Zitvogel L
Cancer Res; 2009 Aug; 69(16):6590-7. PubMed ID: 19679551
[TBL] [Abstract][Full Text] [Related]
30. A simple trogocytosis-based method to detect, quantify, characterize and purify antigen-specific live lymphocytes by flow cytometry, via their capture of membrane fragments from antigen-presenting cells.
Daubeuf S; Puaux AL; Joly E; Hudrisier D
Nat Protoc; 2006; 1(6):2536-42. PubMed ID: 17406507
[TBL] [Abstract][Full Text] [Related]
31. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2.
Mochimaru H; Usui T; Yaguchi T; Nagahama Y; Hasegawa G; Usui Y; Shimmura S; Tsubota K; Amano S; Kawakami Y; Ishida S
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2172-7. PubMed ID: 18263815
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic T-cell response following mouse liver transplantation is independent of the initial site of T-cell priming.
Klein I; Gassel HJ; Crispe IN
Transplant Proc; 2006 Dec; 38(10):3241-3. PubMed ID: 17175235
[TBL] [Abstract][Full Text] [Related]
33. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
[TBL] [Abstract][Full Text] [Related]
34. Interactions between CD8alphabeta and the TCRalphabeta/CD3-receptor complex.
Rubin B; Riond J; Leghait J; Gairin JE
Scand J Immunol; 2006 Sep; 64(3):260-70. PubMed ID: 16918695
[TBL] [Abstract][Full Text] [Related]
35. Cross-presentation of antigens by dendritic cells.
Belz GT; Carbone FR; Heath WR
Crit Rev Immunol; 2002; 22(5-6):439-48. PubMed ID: 12803320
[TBL] [Abstract][Full Text] [Related]
36. CD8- dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens.
Backer R; van Leeuwen F; Kraal G; den Haan JM
Eur J Immunol; 2008 Feb; 38(2):370-80. PubMed ID: 18200498
[TBL] [Abstract][Full Text] [Related]
37. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides.
Mittendorf EA; Storrer CE; Shriver CD; Ponniah S; Peoples GE
Breast Cancer Res Treat; 2005 Jul; 92(1):85-93. PubMed ID: 15980996
[TBL] [Abstract][Full Text] [Related]
39. Division of labor by dendritic cells.
Iwasaki A
Cell; 2007 Feb; 128(3):435-6. PubMed ID: 17289563
[TBL] [Abstract][Full Text] [Related]
40. Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs.
Machlenkin A; Uzana R; Frankenburg S; Eisenberg G; Eisenbach L; Pitcovski J; Gorodetsky R; Nissan A; Peretz T; Lotem M
Cancer Res; 2008 Mar; 68(6):2006-13. PubMed ID: 18339883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
